Alnylam Pharmaceuticals (ALNY.MX) Q3 2017 Earnings

9AugConfirmed
Q4 2016
Q1 2017
Q2 2017
Q3 2017
-28.06
-25.65
-23.23
-20.82

Details

Expected EPS
-20.8181488
Actual EPS
-24.048551200000002
Surprise EPS
-3.23
Surprise Percent
+15.52%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -24.048551200000002 per share for Q3 2017.

0 Comments

Share your thoughts